{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:47:36Z","timestamp":1792144056741,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200982"],"award-info":[{"award-number":["81200982"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11064-016-2125-4","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T22:57:22Z","timestamp":1481237842000},"page":"686-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models"],"prefix":"10.1007","volume":"42","author":[{"given":"Manru","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"2125_CR1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","volume":"158","author":"V Brinkmann","year":"2009","unstructured":"Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Brit J Pharmacol 158:1173\u20131182.","journal-title":"Brit J Pharmacol"},{"key":"2125_CR2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/np2000528","volume":"74","author":"CR Strader","year":"2011","unstructured":"Strader CR, Pearce CJ, Oberlies NH (2011) Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. J Nat Prod 74:900\u2013907","journal-title":"J Nat Prod"},{"key":"2125_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fncel.2014.00283","volume":"8","author":"R Brunkhorst","year":"2014","unstructured":"Brunkhorst R, Vutukuri R, Pfeilschifter W (2014) Fingolimod for the treatment of neurological diseases-state of play and future perspectives. Front Cell Neurosci 8:283","journal-title":"Front Cell Neurosci"},{"key":"2125_CR4","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","volume":"109","author":"R Deogracias","year":"2012","unstructured":"Deogracias R, Yazdani M, Dekkers MP, Guy J, Ionescu MC, Vogt KE, Barde YA (2012) Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci USA 109:14230\u201314235","journal-title":"Proc Natl Acad Sci USA"},{"key":"2125_CR5","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Pardo Di","year":"2014","unstructured":"Di Pardo A, Amico E, Favellato M, Castrataro R, Fucile S, Squitieri F, Maglione V (2014) FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum Mol Genet 23:2251\u20132265","journal-title":"Hum Mol Genet"},{"key":"2125_CR6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroscience.2015.01.032","volume":"290","author":"M Sivasubramanian","year":"2015","unstructured":"Sivasubramanian M, Kanagaraj N, Dheen ST, Tay SS (2015) Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson\u2019s disease and in MPP+ -treated MN9D cells in vitro. Neuroscience 290:636\u2013648","journal-title":"Neuroscience"},{"key":"2125_CR7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ml500128g","volume":"5","author":"J Vargas-Medrano","year":"2014","unstructured":"Vargas-Medrano J, Krishnamachari S, Villanueva E, Godfrey WH, Lou H, Chinnasamy R, Arterburn, JB, Perez RG (2014) Novel FTY720-based compounds stimulate neurotrophin expression and phosphatase activity in dopaminergic cells. ACS Med Chem Lett 5:782\u2013786.","journal-title":"ACS Med Chem Lett"},{"key":"2125_CR8","doi-asserted-by":"crossref","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","volume":"291","author":"G Vidal-Mart\u00ednez","year":"2016","unstructured":"Vidal-Mart\u00ednez G, Vargas-Medrano J, Gil-Tommee C, Medina D, Garza NT, Yang B, Segura-Ulate I, Dominguez SJ, Perez RG (2016) FTY720\/fingolimod reduces synucleinopathy and improves gut motility in A53T mice: contribution of pro-brain-derived neurotrophic factor (pro-BDNF) and mature BDNF. J Biol Chem 291:20811\u201320821","journal-title":"J Biol Chem"},{"key":"2125_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to imagej: 25\u00a0years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"2125_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.11.026","volume":"79","author":"H Lou","year":"2014","unstructured":"Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X (2014) Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2\/ARE signaling pathway. Neuropharmacology 79:380\u2013388","journal-title":"Neuropharmacology"},{"key":"2125_CR11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1471-4159.2005.03587.x","volume":"96","author":"AP Signore","year":"2006","unstructured":"Signore AP, Weng Z, Hastings T, Van Laar AD, Liang Q, Lee YJ, Chen J (2006) Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J Neurochem 96:428\u2013443","journal-title":"J Neurochem"},{"key":"2125_CR12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jchromb.2011.02.011","volume":"879","author":"KY Zhu","year":"2011","unstructured":"Zhu KY, Fu Q, Leung KW, Wong ZC, Choi RC, Tsim KW (2011) The establishment of a sensitive method in determining different neurotransmitters simultaneously in rat brains by using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:737\u2013742","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2125_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2014.03.046","volume":"268","author":"K Fukumoto","year":"2014","unstructured":"Fukumoto K, Mizoguchi H, Takeuchi H, Horiuchi H, Kawanokuchi J, Jin S, Mizuno T, Suzumura A (2014) Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid beta-induced memory impairment. Behav Brain Res 268:88\u201393","journal-title":"Behav Brain Res"},{"key":"2125_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2013.06.016","volume":"252","author":"F Hemmati","year":"2013","unstructured":"Hemmati F, Dargahi L, Nasoohi S, Omidbakhsh R, Mohamed Z, Chik Z, Naidu M, Ahmadiani A (2013) Neurorestorative effect of FTY720 in a rat model of Alzheimer\u2019s disease: comparison with memantine. Behav Brain Res 252:415\u2013421","journal-title":"Behav Brain Res"},{"key":"2125_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.22186","volume":"69","author":"Y Wei","year":"2011","unstructured":"Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119\u2013129","journal-title":"Ann Neurol"},{"key":"2125_CR16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00415-009-5357-2","volume":"257","author":"P Scalzo","year":"2010","unstructured":"Scalzo P, Kummer A, Bretas TL, Cardoso F, Teixeira AL (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson\u2019s disease. J Neurol 257:540\u2013545","journal-title":"J Neurol"},{"key":"2125_CR17","doi-asserted-by":"crossref","first-page":"e0117391","DOI":"10.1371\/journal.pone.0117391","volume":"10","author":"LF Razgado-Hernandez","year":"2015","unstructured":"Razgado-Hernandez LF, Espadas-Alvarez AJ, Reyna-Velazquez P, Sierra-Sanchez A, Anaya-Martinez V, Jimenez-Estrada I, Bannon MJ, Martinez-Fong D, Aceves-Ruiz J (2015) The transfection of BDNF to dopamine neurons potentiates the effect of dopamine d3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson\u2019s disease. PloS One 10:e0117391","journal-title":"PloS One"},{"key":"2125_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jnc.13116","volume":"134","author":"H Sano","year":"2015","unstructured":"Sano H, Murata M, Nambu A (2015) Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson\u2019s disease. J Neurochem 134:371\u2013381","journal-title":"J Neurochem"},{"key":"2125_CR19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-015-0308-6","volume":"12","author":"R Cipriani","year":"2015","unstructured":"Cipriani R, Chara JC, Rodriguez-Antiguedad A, Matute C (2015) FTY720 attenuates excitotoxicity and neuroinflammation. J Neuroinflamm 12:86","journal-title":"J Neuroinflamm"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-2125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-016-2125-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-2125-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:34:02Z","timestamp":1498354442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-016-2125-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2125"],"URL":"https:\/\/doi.org\/10.1007\/s11064-016-2125-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}